Fig. 1
From: Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
Entry of SARS-CoV-2 into host cells depends on ACE2 and TMPRSS2, and effective treatment strategies can prevent this process. For example, a Antibodies raised against SARS-S could cross-neutralize SARS-2-S. b Camostat mesylate inhibits TMPRSS2 and interferes with this process.
